{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T07:01:59Z","timestamp":1790406119020,"version":"4.1.0"},"reference-count":136,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Anhui International Collaborative Project","award":["160521602"],"award-info":[{"award-number":["160521602"]}]},{"name":"Anhui Natural Science Research Fund","award":["160511608"],"award-info":[{"award-number":["160511608"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology Letters"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.imlet.2017.01.010","type":"journal-article","created":{"date-parts":[[2017,1,30]],"date-time":"2017-01-30T18:32:11Z","timestamp":1485801131000},"page":"86-95","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":83,"special_numbering":"C","title":["CD19, from bench to bedside"],"prefix":"10.1016","volume":"183","author":[{"given":"Xinchen","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengting","family":"Zi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuekang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.imlet.2017.01.010_bib0005","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.4049\/jimmunol.1301361","article-title":"CD19 and CD32b differentially regulate human B cell responsiveness","volume":"192","author":"Karnell","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.imlet.2017.01.010_bib0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0065-2776(05)88001-0","article-title":"CD22: a multifunctional receptor that regulates B lymphocyte survival and signal transduction","volume":"88","author":"Tedder","year":"2005","journal-title":"Adv. Immunol."},{"key":"10.1016\/j.imlet.2017.01.010_bib0015","doi-asserted-by":"crossref","first-page":"739","DOI":"10.3109\/08830180109045588","article-title":"CD19, CD21, and CD22: multifaceted response regulators of B lymphocyte signal transduction","volume":"20","author":"Poe","year":"2001","journal-title":"Int. Rev. Immunol."},{"key":"10.1016\/j.imlet.2017.01.010_bib0020","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.4049\/jimmunol.164.3.1223","article-title":"CD72 negatively regulates signaling through the antigen receptor of B cells","volume":"164","author":"Adachi","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.imlet.2017.01.010_bib0025","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1600-065X.1997.tb01033.x","article-title":"Co-receptor and accessory regulation of B-cell antigen receptor signal transduction","volume":"160","author":"Buhl","year":"1997","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.imlet.2017.01.010_bib0030","doi-asserted-by":"crossref","first-page":"4371","DOI":"10.4049\/jimmunol.157.10.4371","article-title":"CD19 regulates B lymphocyte thresholds critical for the development of B-1 lineage cells and autoimmunity","volume":"157","author":"Sato","year":"1996","journal-title":"J. Immunol."},{"key":"10.1016\/j.imlet.2017.01.010_bib0035","doi-asserted-by":"crossref","first-page":"4662","DOI":"10.4049\/jimmunol.158.10.4662","article-title":"CD19 expression levels regulate B lymphocyte development: human CD19 restores normal function in mice lacking endogenous CD19","volume":"158","author":"Sato","year":"1997","journal-title":"J. Immunol."},{"key":"10.1016\/j.imlet.2017.01.010_bib0040","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.4049\/jimmunol.151.6.2915","article-title":"The CD19 signal transduction complex of B lymphocytes. Deletion of the CD19 cytoplasmic domain alters signal transduction but not complex formation with TAPA-1 and Leu 13","volume":"151","author":"Bradbury","year":"1993","journal-title":"J. Immunol."},{"key":"10.1016\/j.imlet.2017.01.010_bib0045","doi-asserted-by":"crossref","first-page":"712","DOI":"10.4049\/jimmunol.143.2.712","article-title":"Isolation of cDNAs encoding the CD19 antigen of human and mouse B lymphocytes: a new member of the immunoglobulin superfamily","volume":"143","author":"Tedder","year":"1989","journal-title":"J. Immunol."},{"key":"10.1016\/j.imlet.2017.01.010_bib0050","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.4049\/jimmunol.147.4.1424","article-title":"Structure and domain organization of the CD19 antigen of human, mouse, and guinea pig B lymphocytes Conservation of the extensive cytoplasmic domain","volume":"147","author":"Zhou","year":"1991","journal-title":"J. Immunol."},{"key":"10.1016\/j.imlet.2017.01.010_bib0055","doi-asserted-by":"crossref","first-page":"7088","DOI":"10.4049\/jimmunol.162.12.7088","article-title":"CD19 amplifies B lymphocyte signal transduction by regulating Src-family protein tyrosine kinase activation","volume":"162","author":"Fujimoto","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.imlet.2017.01.010_bib0060","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1002\/j.1460-2075.1993.tb05930.x","article-title":"Tyrosine phosphorylation of CD19 in pre-B and mature B cells","volume":"12","author":"Chalupny","year":"1993","journal-title":"EMBO J."},{"key":"10.1016\/j.imlet.2017.01.010_bib0065","doi-asserted-by":"crossref","first-page":"3502","DOI":"10.1182\/blood.V88.9.3502.bloodjournal8893502","article-title":"The protein product of the proto-oncogene c-cbl forms a complex with phosphatidylinositol 3-kinase p85 and CD19 in anti-IgM-stimulated human B-lymphoma cells","volume":"88","author":"Beckwith","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.imlet.2017.01.010_bib0070","doi-asserted-by":"crossref","first-page":"2818","DOI":"10.1002\/eji.1830241136","article-title":"B cell antigen receptor cross-linking induces tyrosine phosphorylation and membrane translocation of a multimeric Shc complex that is augmented by CD19 co-ligation","volume":"24","author":"Lankester","year":"1994","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.imlet.2017.01.010_bib0075","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S1074-7613(00)80568-3","article-title":"CD19 as a membrane-anchored adaptor protein of B lymphocytes: costimulation of lipid and protein kinases by recruitment of Vav","volume":"8","author":"O'Rourke","year":"1998","journal-title":"Immunity"},{"key":"10.1016\/j.imlet.2017.01.010_bib0080","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1084\/jem.186.11.1923","article-title":"CD19-regulated signaling thresholds control peripheral tolerance and autoantibody production in B lymphocytes","volume":"186","author":"Inaoki","year":"1997","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.imlet.2017.01.010_bib0085","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S1074-7613(00)80510-5","article-title":"Counterregulation by the coreceptors CD19 and CD22 of MAP kinase activation by membrane immunoglobulin","volume":"7","author":"Tooze","year":"1997","journal-title":"Immunity"},{"key":"10.1016\/j.imlet.2017.01.010_bib0090","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1126\/science.7684160","article-title":"CD19 of B cells as a surrogate kinase insert region to bind phosphatidylinositol 3-kinase","volume":"260","author":"Tuveson","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.imlet.2017.01.010_bib0095","doi-asserted-by":"crossref","first-page":"32514","DOI":"10.1016\/S0021-9258(18)31664-8","article-title":"Signaling through CD19 activates Vav\/mitogen-activated protein kinase pathway and induces formation of a CD19\/Vav\/phosphatidylinositol 3-kinase complex in human B cell precursors","volume":"269","author":"Weng","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.imlet.2017.01.010_bib0100","doi-asserted-by":"crossref","first-page":"6872","DOI":"10.4049\/jimmunol.165.12.6872","article-title":"The c-Abl tyrosine kinase is regulated downstream of the B cell antigen receptor and interacts with CD19","volume":"165","author":"Zipfel","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.imlet.2017.01.010_bib0105","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1126\/science.1373518","article-title":"CD19: lowering the threshold for antigen receptor stimulation of B lymphocytes","volume":"256","author":"Carter","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.imlet.2017.01.010_bib0110","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S1074-7613(00)00007-8","article-title":"CD19 regulates Src family protein tyrosine kinase activation in B lymphocytes through processive amplification","volume":"13","author":"Fujimoto","year":"2000","journal-title":"Immunity"},{"key":"10.1016\/j.imlet.2017.01.010_bib0115","doi-asserted-by":"crossref","first-page":"3663","DOI":"10.4049\/jimmunol.147.11.3663","article-title":"The CD19 complex of B lymphocytes: activation of phospholipase C by a protein tyrosine kinase-dependent pathway that can be enhanced by the membrane IgM complex","volume":"147","author":"Carter","year":"1991","journal-title":"J. Immunol."},{"key":"10.1016\/j.imlet.2017.01.010_bib0120","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.4049\/jimmunol.148.10.2983","article-title":"CD19 regulation of human B cell responses: b cell proliferation and antibody secretion are inhibited or enhanced by ligation of the CD19 surface glycoprotein depending on the stimulating signal used","volume":"148","author":"Callard","year":"1992","journal-title":"J. Immunol."},{"key":"10.1016\/j.imlet.2017.01.010_bib0125","doi-asserted-by":"crossref","first-page":"44820","DOI":"10.1074\/jbc.M107559200","article-title":"CD19 amplification of B lymphocyte Ca2+ responses: a role for Lyn sequestration in extinguishing negative regulation","volume":"276","author":"Fujimoto","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.imlet.2017.01.010_bib0130","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.4049\/jimmunol.138.9.2793","article-title":"CD19 monoclonal antibody HD37 inhibits anti-immunoglobulin-induced B cell activation and proliferation","volume":"138","author":"Pezzutto","year":"1987","journal-title":"J. Immunol."},{"key":"10.1016\/j.imlet.2017.01.010_bib0135","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1002\/eji.1830210302","article-title":"Inhibition of B cell proliferation with anti-CD19 monoclonal antibodies: anti-CD19 antibodies do not interfere with early signaling events triggered by anti-IgM or interleukin 4","volume":"21","author":"Rigley","year":"1991","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.imlet.2017.01.010_bib0140","doi-asserted-by":"crossref","first-page":"430","DOI":"10.3109\/08916934.2014.921810","article-title":"CD19 differentially regulates BCR signalling through the recruitment of PI3K","volume":"47","author":"Xu","year":"2014","journal-title":"Autoimmunity"},{"key":"10.1016\/j.imlet.2017.01.010_bib0145","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.4049\/jimmunol.1201000","article-title":"A c-Myc and surface CD19 signaling amplification loop promotes B cell lymphoma development and progression in mice","volume":"189","author":"Poe","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.imlet.2017.01.010_bib0150","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/nrrheum.2009.184","article-title":"CD19: a promising B cell target for rheumatoid arthritis","volume":"5","author":"Tedder","year":"2009","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.imlet.2017.01.010_bib0155","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1056\/NEJMoa051568","article-title":"An antibody-deficiency syndrome due to mutations in the CD19 gene","volume":"354","author":"van Zelm","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.imlet.2017.01.010_bib0160","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/cyto.b.20030","article-title":"Diminished expression of CD19 in B-cell lymphomas","volume":"63","author":"Yang","year":"2005","journal-title":"Cytometry B Clin. Cytom."},{"key":"10.1016\/j.imlet.2017.01.010_bib0165","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1136\/jcp.51.5.364","article-title":"Levels of expression of CD19 and CD20 in chronic B cell leukaemias","volume":"51","author":"Ginaldi","year":"1998","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.imlet.2017.01.010_bib0170","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.2353\/ajpath.2008.071049","article-title":"CD19 regulates skin and lung fibrosis via toll-like receptor signaling in a model of bleomycin-induced scleroderma","volume":"172","author":"Yoshizaki","year":"2008","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.imlet.2017.01.010_bib0175","doi-asserted-by":"crossref","first-page":"6635","DOI":"10.4049\/jimmunol.165.11.6635","article-title":"Quantitative genetic variation in CD19 expression correlates with autoimmunity","volume":"165","author":"Sato","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.imlet.2017.01.010_bib0180","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s00109-015-1252-8","article-title":"Signaling mechanisms regulating B-lymphocyte activation and tolerance","volume":"93","author":"Hobeika","year":"2015","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.imlet.2017.01.010_bib0185","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.cell.2009.08.041","article-title":"PI3 kinase signals BCR-dependent mature B cell survival","volume":"139","author":"Srinivasan","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.imlet.2017.01.010_bib0190","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1080\/08916930902911746","article-title":"The p85beta regulatory subunit of phosphoinositide 3-kinase has unique and redundant functions in B cells","volume":"42","author":"Oak","year":"2009","journal-title":"Autoimmunity"},{"key":"10.1016\/j.imlet.2017.01.010_bib0195","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/ni.1749","article-title":"Essential function for the GTPase TC21 in homeostatic antigen receptor signaling","volume":"10","author":"Delgado","year":"2009","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.imlet.2017.01.010_bib0200","doi-asserted-by":"crossref","first-page":"146","DOI":"10.3109\/08830185.2014.885022","article-title":"FOXO1 transcription factor: a critical effector of the PI3K-AKT axis in B-cell development","volume":"33","author":"Szydlowski","year":"2014","journal-title":"Int. Rev. Immunol."},{"key":"10.1016\/j.imlet.2017.01.010_bib0205","doi-asserted-by":"crossref","first-page":"282","DOI":"10.4161\/sgtp.2.5.17794","article-title":"Ca-dependent Ras\/Erk signaling mediates negative selection of autoreactive B cells","volume":"2","author":"Limnander","year":"2011","journal-title":"Small GTPases"},{"key":"10.1016\/j.imlet.2017.01.010_bib0210","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0952-7915(00)00089-3","article-title":"Ras regulation and function in lymphocytes","volume":"12","author":"Genot","year":"2000","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.imlet.2017.01.010_bib0215","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1101\/gad.12.13.1953","article-title":"Antigen receptor signaling induces MAP kinase-mediated phosphorylation and degradation of the BCL-6 transcription factor","volume":"12","author":"Niu","year":"1998","journal-title":"Genes Dev."},{"key":"10.1016\/j.imlet.2017.01.010_bib0220","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1038\/ni.1764","article-title":"Recruitment of the cytoplasmic adaptor Grb2 to surface IgG and IgE provides antigen receptor-intrinsic costimulation to class-switched B cells","volume":"10","author":"Engels","year":"2009","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.imlet.2017.01.010_bib0225","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/nrc3702","article-title":"Targeting Bruton's tyrosine kinase in B cell malignancies","volume":"14","author":"Hendriks","year":"2014","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.imlet.2017.01.010_bib0230","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.coi.2008.04.004","article-title":"Calcium signaling in lymphocytes","volume":"20","author":"Oh-hora","year":"2008","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.imlet.2017.01.010_bib0235","doi-asserted-by":"crossref","first-page":"3278","DOI":"10.4049\/jimmunol.159.7.3278","article-title":"Regulation of B lymphocyte development and activation by the CD19\/CD21\/CD81\/Leu 13 complex requires the cytoplasmic domain of CD19","volume":"159","author":"Sato","year":"1997","journal-title":"J. Immunol."},{"key":"10.1016\/j.imlet.2017.01.010_bib0240","doi-asserted-by":"crossref","first-page":"9194","DOI":"10.1073\/pnas.84.24.9194","article-title":"Molecular cloning of the cDNA encoding the Epstein-Barr virus\/C3d receptor (complement receptor type 2) of human B lymphocytes","volume":"84","author":"Moore","year":"1987","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.imlet.2017.01.010_bib0245","doi-asserted-by":"crossref","first-page":"5639","DOI":"10.1073\/pnas.83.15.5639","article-title":"Identification of a partial cDNA clone for the C3d\/Epstein-Barr virus receptor of human B lymphocytes: homology with the receptor for fragments C3b and C4b of the third and fourth components of complement","volume":"83","author":"Weis","year":"1986","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.imlet.2017.01.010_bib0250","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1146\/annurev.immunol.18.1.393","article-title":"Regulation of B lymphocyte responses to foreign and self-antigens by the CD19\/CD21 complex","volume":"18","author":"Fearon","year":"2000","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.imlet.2017.01.010_bib0255","doi-asserted-by":"crossref","first-page":"8011","DOI":"10.4049\/jimmunol.175.12.8011","article-title":"Complement component C3d-antigen complexes can either augment or inhibit B lymphocyte activation and humoral immunity in mice depending on the degree of CD21\/CD19 complex engagement","volume":"175","author":"Lee","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.imlet.2017.01.010_bib0260","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.4049\/jimmunol.149.9.2841","article-title":"The CD19\/CD21 signal transducing complex of human B lymphocytes includes the target of antiproliferative antibody-1 and Leu-13 molecules","volume":"149","author":"Bradbury","year":"1992","journal-title":"J. Immunol."},{"key":"10.1016\/j.imlet.2017.01.010_bib0265","doi-asserted-by":"crossref","first-page":"10844","DOI":"10.1073\/pnas.94.20.10844","article-title":"Impaired CD19 expression and signaling, enhanced antibody response to type II T independent antigen and reduction of B-1 cells in CD81-deficient mice","volume":"94","author":"Tsitsikov","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.imlet.2017.01.010_bib0270","doi-asserted-by":"crossref","first-page":"4217","DOI":"10.1093\/emboj\/16.14.4217","article-title":"Normal development but differentially altered proliferative responses of lymphocytes in mice lacking CD81","volume":"16","author":"Miyazaki","year":"1997","journal-title":"EMBO J."},{"key":"10.1016\/j.imlet.2017.01.010_bib0275","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1084\/jem.185.8.1505","article-title":"Normal lymphocyte development but delayed humoral immune response in CD81-null mice","volume":"185","author":"Maecker","year":"1997","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.imlet.2017.01.010_bib0280","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2302\/kjm.49.1","article-title":"CD19 and CD22 regulate a B lymphocyte signal transduction pathway that contributes to autoimmunity","volume":"49","author":"Tedder","year":"2000","journal-title":"Keio J. Med."},{"key":"10.1016\/j.imlet.2017.01.010_bib0285","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/0-387-24180-9_16","article-title":"Role of the CD19 and CD21\/35 receptor complex in innate immunity, host defense and autoimmunity","volume":"560","author":"Haas","year":"2005","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.imlet.2017.01.010_bib0290","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/BF00189519","article-title":"Structure of the genes encoding the CD19 antigen of human and mouse B lymphocytes","volume":"35","author":"Zhou","year":"1992","journal-title":"Immunogenetics"},{"key":"10.1016\/j.imlet.2017.01.010_bib0295","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.immuni.2005.04.012","article-title":"CD19 regulates B cell maturation, proliferation, and positive selection in the FDC zone of murine splenic germinal centers","volume":"22","author":"Wang","year":"2005","journal-title":"Immunity"},{"key":"10.1016\/j.imlet.2017.01.010_bib0300","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S1074-7613(02)00426-0","article-title":"The physiologic role of CD19 cytoplasmic tyrosines","volume":"17","author":"Wang","year":"2002","journal-title":"Immunity"},{"key":"10.1016\/j.imlet.2017.01.010_bib0305","doi-asserted-by":"crossref","first-page":"4438","DOI":"10.4049\/jimmunol.162.8.4438","article-title":"Phosphorylation of CD19 Y484 and Y515, and linked activation of phosphatidylinositol 3-kinase, are required for B cell antigen receptor-mediated activation of Bruton's tyrosine kinase","volume":"162","author":"Buhl","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.imlet.2017.01.010_bib0310","doi-asserted-by":"crossref","first-page":"3062","DOI":"10.4049\/jimmunol.158.7.3062","article-title":"Membrane IgM-induced tyrosine phosphorylation of CD19 requires a CD19 domain that mediates association with components of the B cell antigen receptor complex","volume":"158","author":"Carter","year":"1997","journal-title":"J. Immunol."},{"key":"10.1016\/j.imlet.2017.01.010_bib0315","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1084\/jem.186.11.1897","article-title":"Qualitative regulation of B cell antigen receptor signaling by CD19: selective requirement for PI3-kinase activation, inositol-1,4,5-trisphosphate production and Ca2+ mobilization","volume":"186","author":"Buhl","year":"1997","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.imlet.2017.01.010_bib0320","doi-asserted-by":"crossref","first-page":"5649","DOI":"10.4049\/jimmunol.158.12.5649","article-title":"Role of CD19 tyrosine 391 in synergistic activation of B lymphocytes by coligation of CD19 and membrane Ig","volume":"158","author":"Li","year":"1997","journal-title":"J. Immunol."},{"key":"10.1016\/j.imlet.2017.01.010_bib0325","doi-asserted-by":"crossref","first-page":"3209","DOI":"10.4049\/jimmunol.173.5.3209","article-title":"Vav-dependent and vav-independent phosphatidylinositol 3-kinase activation in murine B cells determined by the nature of the stimulus","volume":"173","author":"Vigorito","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.imlet.2017.01.010_bib0330","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/376352a0","article-title":"Impairment of T-cell-dependent B-cell responses and B-1 cell development in CD19-deficient mice","volume":"376","author":"Rickert","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.imlet.2017.01.010_bib0335","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/1074-7613(95)90157-4","article-title":"Abnormal B lymphocyte development, activation, and differentiation in mice that lack or overexpress the CD19 signal transduction molecule","volume":"3","author":"Engel","year":"1995","journal-title":"Immunity"},{"key":"10.1016\/j.imlet.2017.01.010_bib0340","doi-asserted-by":"crossref","first-page":"11558","DOI":"10.1073\/pnas.92.25.11558","article-title":"The CD19 signal transduction molecule is a response regulator of B-lymphocyte differentiation","volume":"92","author":"Sato","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.imlet.2017.01.010_bib0345","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.imlet.2014.01.011","article-title":"The selection of mature B cells is critically dependent on the expression level of the co-receptor CD19","volume":"160","author":"von Muenchow","year":"2014","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.imlet.2017.01.010_bib0350","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S1074-7613(00)80418-5","article-title":"The CD19-CD21 complex regulates signal transduction thresholds governing humoral immunity and autoimmunity","volume":"6","author":"Tedder","year":"1997","journal-title":"Immunity"},{"key":"10.1016\/j.imlet.2017.01.010_bib0355","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/sj.gene.6364431","article-title":"Novel mutations in a Japanese patient with CD19 deficiency","volume":"8","author":"Kanegane","year":"2007","journal-title":"Genes Immun."},{"key":"10.1016\/j.imlet.2017.01.010_bib0360","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1159\/000082087","article-title":"The CD19-CD21 signal transduction complex of B lymphocytes regulates the balance between health and autoimmune disease: systemic sclerosis as a model system","volume":"8","author":"Tedder","year":"2005","journal-title":"Curr. Dir. Autoimmun."},{"key":"10.1016\/j.imlet.2017.01.010_bib0365","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.jaci.2011.09.027","article-title":"Genetic CD21 deficiency is associated with hypogammaglobulinemia","volume":"129","author":"Thiel","year":"2012","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.imlet.2017.01.010_bib0370","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.jaci.2011.12.982","article-title":"CD21 deficiency, complement, and the development of common variable immunodeficiency","volume":"129","author":"Frank","year":"2012","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.imlet.2017.01.010_bib0375","doi-asserted-by":"crossref","first-page":"7270","DOI":"10.1073\/pnas.0402253101","article-title":"CD81 is an entry coreceptor for hepatitis C virus","volume":"101","author":"Cormier","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.imlet.2017.01.010_bib0380","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/nm808","article-title":"Hepatocyte CD81 is required for Plasmodium falciparum and Plasmodium yoelii sporozoite infectivity","volume":"9","author":"Silvie","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.imlet.2017.01.010_bib0385","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1742-4690-6-28","article-title":"A role for CD81 on the late steps of HIV-1 replication in a chronically infected T cell line","volume":"6","author":"Grigorov","year":"2009","journal-title":"Retrovirology"},{"key":"10.1016\/j.imlet.2017.01.010_bib0390","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1172\/JCI39748","article-title":"CD81 gene defect in humans disrupts CD19 complex formation and leads to antibody deficiency","volume":"120","author":"van Zelm","year":"2010","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.imlet.2017.01.010_bib0395","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.immuni.2015.09.004","article-title":"Wiskott-Aldrich syndrome interacting protein deficiency uncovers the role of the co-receptor CD19 as a generic hub for PI3 kinase signaling in B cells","volume":"43","author":"Keppler","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.imlet.2017.01.010_bib0400","doi-asserted-by":"crossref","first-page":"5465","DOI":"10.4049\/jimmunol.168.11.5465","article-title":"Complementary roles for CD19 and Bruton's tyrosine kinase in B lymphocyte signal transduction","volume":"168","author":"Fujimoto","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.imlet.2017.01.010_bib0405","doi-asserted-by":"crossref","first-page":"5901","DOI":"10.4049\/jimmunol.161.11.5901","article-title":"Convergence of CD19 and B cell antigen receptor signals at MEK1 in the ERK2 activation cascade","volume":"161","author":"Li","year":"1998","journal-title":"J. Immunol."},{"key":"10.1016\/j.imlet.2017.01.010_bib0410","doi-asserted-by":"crossref","first-page":"7538","DOI":"10.1016\/S0021-9258(17)37320-9","article-title":"Cross-linking of surface IgM stimulates the Ras\/Raf-1\/MEK\/MAPK cascade in human B lymphocytes","volume":"269","author":"Tordai","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.imlet.2017.01.010_bib0415","doi-asserted-by":"crossref","first-page":"623","DOI":"10.4049\/jimmunol.153.2.623","article-title":"B cell antigen receptor cross-linking induces phosphorylation of the p21ras oncoprotein activators SHC and mSOS1 as well as assembly of complexes containing SHC, GRB-2, mSOS1, and a 145-kDa tyrosine-phosphorylated protein","volume":"153","author":"Saxton","year":"1994","journal-title":"J. Immunol."},{"key":"10.1016\/j.imlet.2017.01.010_bib0420","doi-asserted-by":"crossref","first-page":"4513","DOI":"10.4049\/jimmunol.151.9.4513","article-title":"B cell antigen receptor cross-linking triggers rapid protein kinase C independent activation of p21ras1","volume":"151","author":"Harwood","year":"1993","journal-title":"J. Immunol."},{"key":"10.1016\/j.imlet.2017.01.010_bib0425","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.4049\/jimmunol.164.6.3123","article-title":"Systematic analysis of the role of CD19 cytoplasmic tyrosines in enhancement of activation in Daudi human B cells: clustering of phospholipase C and Vav and of Grb2 and Sos with different CD19 tyrosines","volume":"164","author":"Brooks","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.imlet.2017.01.010_bib0430","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1006\/smim.1998.0122","article-title":"Positive and negative roles of the tyrosine kinase Lyn in B cell function","volume":"10","author":"DeFranco","year":"1998","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.imlet.2017.01.010_bib0435","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.4049\/jimmunol.167.5.2469","article-title":"A CD19-dependent signaling pathway regulates autoimmunity in Lyn-deficient mice","volume":"167","author":"Hasegawa","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.imlet.2017.01.010_bib0440","doi-asserted-by":"crossref","first-page":"6910","DOI":"10.4049\/jimmunol.169.12.6910","article-title":"The activation and subsequent regulatory roles of Lyn and CD19 after B cell receptor ligation are independent","volume":"169","author":"Xu","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.imlet.2017.01.010_bib0445","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/ni1337","article-title":"Quantitative proteomic analysis of B cell lipid rafts reveals that ezrin regulates antigen receptor-mediated lipid raft dynamics","volume":"7","author":"Gupta","year":"2006","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.imlet.2017.01.010_bib0450","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1091\/mbc.02-05-0078","article-title":"Visualizing lipid raft dynamics and early signaling events during antigen receptor-mediated B-lymphocyte activation","volume":"14","author":"Gupta","year":"2003","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.imlet.2017.01.010_bib0455","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S1074-7613(01)00098-X","article-title":"The CD19\/CD21 complex functions to prolong B cell antigen receptor signaling from lipid rafts","volume":"14","author":"Cherukuri","year":"2001","journal-title":"Immunity"},{"key":"10.1016\/j.imlet.2017.01.010_bib0460","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1189\/jlb.2A0614-287RR","article-title":"The synaptic recruitment of lipid rafts is dependent on CD19-PI3K module and cytoskeleton remodeling molecules","volume":"98","author":"Xu","year":"2015","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.imlet.2017.01.010_bib0465","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.it.2011.09.004","article-title":"Impact of Ca2+ signaling on B cell function","volume":"32","author":"Baba","year":"2011","journal-title":"Trends Immunol."},{"key":"10.1016\/j.imlet.2017.01.010_bib0470","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1100\/tsw.2010.219","article-title":"Ca(2)+ signaling in B cells","volume":"10","author":"Lyubchenko","year":"2010","journal-title":"Sci. World J."},{"key":"10.1016\/j.imlet.2017.01.010_bib0475","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1600-065X.2010.00934.x","article-title":"Role of PI3K in the generation and survival of B cells","volume":"237","author":"Werner","year":"2010","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.imlet.2017.01.010_bib0480","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.coi.2011.01.001","article-title":"Emergence of the PI3-kinase pathway as a central modulator of normal and aberrant B cell differentiation","volume":"23","author":"Baracho","year":"2011","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.imlet.2017.01.010_bib0485","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1182\/blood-2007-08-109769","article-title":"Regulation of B-cell development by BCAP and CD19 through their binding to phosphoinositide 3-kinase","volume":"111","author":"Aiba","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.imlet.2017.01.010_bib0490","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S1074-7613(00)00079-0","article-title":"BCAP: the tyrosine kinase substrate that connects B cell receptor to phosphoinositide 3-kinase activation","volume":"13","author":"Okada","year":"2000","journal-title":"Immunity"},{"key":"10.1016\/j.imlet.2017.01.010_bib0495","doi-asserted-by":"crossref","first-page":"3884","DOI":"10.1128\/MCB.14.6.3884","article-title":"Tissue-specific expression of the human CD19 gene in transgenic mice inhibits antigen-independent B-lymphocyte development","volume":"14","author":"Zhou","year":"1994","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.imlet.2017.01.010_bib0500","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1007\/s00125-013-3038-2","article-title":"The CD19 signalling molecule is elevated in NOD mice and controls type 1 diabetes development","volume":"56","author":"Ziegler","year":"2013","journal-title":"Diabetologia"},{"key":"10.1016\/j.imlet.2017.01.010_bib0505","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1056\/NEJMra0806188","article-title":"Scleroderma","volume":"360","author":"Gabrielli","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.imlet.2017.01.010_bib0510","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/nri1838","article-title":"B-cell targeting in rheumatoid arthritis and other autoimmune diseases","volume":"6","author":"Edwards","year":"2006","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.imlet.2017.01.010_bib0515","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s12016-010-8198-y","article-title":"Diagnosis and classification of systemic sclerosis","volume":"40","author":"Hachulla","year":"2011","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.imlet.2017.01.010_bib0520","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1002\/art.20274","article-title":"Altered blood B lymphocyte homeostasis in systemic sclerosis: expanded naive B cells and diminished but activated memory B cells","volume":"50","author":"Sato","year":"2004","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.imlet.2017.01.010_bib0525","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S0002-9440(10)63328-7","article-title":"B Lymphocyte signaling established by the CD19\/CD22 loop regulates autoimmunity in the tight-skin mouse","volume":"165","author":"Asano","year":"2004","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.imlet.2017.01.010_bib0530","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1056\/NEJMra071297","article-title":"Systemic lupus erythematosus","volume":"358","author":"Rahman","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.imlet.2017.01.010_bib0535","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.2165\/00003495-200666150-00004","article-title":"B-cell-targeted therapy for systemic lupus erythematosus","volume":"66","author":"Sabahi","year":"2006","journal-title":"Drugs"},{"key":"10.1016\/j.imlet.2017.01.010_bib0540","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/nrrheum.2014.33","article-title":"The BAFF\/APRIL system in SLE pathogenesis","volume":"10","author":"Vincent","year":"2014","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.imlet.2017.01.010_bib0545","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/iub.1046","article-title":"BAFF\/BLyS inhibitors: a new prospect for treatment of systemic lupus erythematosus","volume":"64","author":"Fairfax","year":"2012","journal-title":"IUBMB Life"},{"key":"10.1016\/j.imlet.2017.01.010_bib0550","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1084\/jem.192.1.129","article-title":"BAFF binds to the tumor necrosis factor receptor-like molecule B cell maturation antigen and is important for maintaining the peripheral B cell population","volume":"192","author":"Thompson","year":"2000","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.imlet.2017.01.010_bib0555","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1084\/jem.190.11.1697","article-title":"Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations","volume":"190","author":"Mackay","year":"1999","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.imlet.2017.01.010_bib0560","doi-asserted-by":"crossref","first-page":"4792","DOI":"10.4049\/jimmunol.1102070","article-title":"FcgammaRIIb and BAFF differentially regulate peritoneal B1 cell survival","volume":"188","author":"Amezcua Vesely","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.imlet.2017.01.010_bib0565","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1084\/jem.192.10.1453","article-title":"BAFF mediates survival of peripheral immature B lymphocytes","volume":"192","author":"Batten","year":"2000","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.imlet.2017.01.010_bib0570","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2015.06.001","article-title":"BAFF-driven autoimmunity requires CD19 expression","volume":"62","author":"Fairfax","year":"2015","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.imlet.2017.01.010_bib0575","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1111\/j.1476-5381.2011.01302.x","article-title":"Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS)","volume":"164","author":"Constantinescu","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.imlet.2017.01.010_bib0580","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1038\/ni833","article-title":"B cells regulate autoimmunity by provision of IL-10","volume":"3","author":"Fillatreau","year":"2002","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.imlet.2017.01.010_bib0585","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.4049\/jimmunol.168.6.3105","article-title":"Increased severity of experimental allergic encephalomyelitis in lyn-\/- mice in the absence of elevated proinflammatory cytokine response in the central nervous system","volume":"168","author":"Du","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.imlet.2017.01.010_bib0590","doi-asserted-by":"crossref","first-page":"812","DOI":"10.2353\/ajpath.2006.050923","article-title":"Inhibitory role of CD19 in the progression of experimental autoimmune encephalomyelitis by regulating cytokine response","volume":"168","author":"Matsushita","year":"2006","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.imlet.2017.01.010_bib0595","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nrc1589","article-title":"Mechanisms of B-cell lymphoma pathogenesis","volume":"5","author":"Kuppers","year":"2005","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.imlet.2017.01.010_bib0600","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.bcmd.2004.03.003","article-title":"Development and application of CD19-specific T cells for adoptive immunotherapy of B cell malignancies","volume":"33","author":"Cooper","year":"2004","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.imlet.2017.01.010_bib0605","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1007\/s10637-015-0289-4","article-title":"Blinatumomab for the treatment of acute lymphoblastic leukemia","volume":"33","author":"Kaplan","year":"2015","journal-title":"Invest. New Drugs"},{"key":"10.1016\/j.imlet.2017.01.010_bib0610","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.3109\/10428194.2011.559668","article-title":"Flow cytometric study of potential target antigens (CD19, CD20, CD22, CD33) for antibody-based immunotherapy in acute lymphoblastic leukemia: analysis of 552 cases","volume":"52","author":"Raponi","year":"2011","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.imlet.2017.01.010_bib0615","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1056\/NEJMoa1407222","article-title":"Chimeric antigen receptor T cells for sustained remissions in leukemia","volume":"371","author":"Maude","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.imlet.2017.01.010_bib0620","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1056\/NEJMoa1215134","article-title":"Chimeric antigen receptor-modified T cells for acute lymphoid leukemia","volume":"368","author":"Grupp","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.imlet.2017.01.010_bib0625","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1056\/NEJMra041720","article-title":"Chronic lymphocytic leukemia","volume":"352","author":"Chiorazzi","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.imlet.2017.01.010_bib0630","doi-asserted-by":"crossref","first-page":"784","DOI":"10.4049\/jimmunol.1200615","article-title":"Divergence in CD19-mediated signaling unfolds intraclonal diversity in chronic lymphocytic leukemia, which correlates with disease progression","volume":"190","author":"Herishanu","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.imlet.2017.01.010_bib0635","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1172\/JCI45851","article-title":"Thomas-Tikhonenko A. CD19 is a major B cell receptor-independent activator of MYC-driven B-lymphomagenesis","volume":"122","author":"Chung","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.imlet.2017.01.010_bib0640","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1158\/1078-0432.CCR-12-3613","article-title":"The anti-CD19 antibody-drug conjugate SAR3419 prevents hematolymphoid relapse postinduction therapy in preclinical models of pediatric acute lymphoblastic leukemia","volume":"19","author":"Carol","year":"2013","journal-title":"Clin. Cancer Res.: Off. J. Am. Assoc. Cancer Res."},{"key":"10.1016\/j.imlet.2017.01.010_bib0645","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1002\/art.38334","article-title":"Suppression of rheumatoid arthritis B cells by XmAb5871, an anti-CD19 antibody that coengages B cell antigen receptor complex and Fcgamma receptor IIb inhibitory receptor","volume":"66","author":"Chu","year":"2014","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.imlet.2017.01.010_bib0650","doi-asserted-by":"crossref","first-page":"4223","DOI":"10.4049\/jimmunol.1003412","article-title":"Antibody-mediated coengagement of FcgammaRIIb and B cell receptor complex suppresses humoral immunity in systemic lupus erythematosus","volume":"186","author":"Horton","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.imlet.2017.01.010_bib0655","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1124\/jpet.110.168062","article-title":"B-cell depletion in vitro and in vivo with an afucosylated anti-CD19 antibody","volume":"335","author":"Herbst","year":"2010","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.imlet.2017.01.010_bib0660","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s13075-016-1021-2","article-title":"Safety and tolerability of an anti-CD19 monoclonal antibody, MEDI-551, in subjects with systemic sclerosis: a phase I, randomized, placebo-controlled, escalating single-dose study","volume":"18","author":"Schiopu","year":"2016","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.imlet.2017.01.010_bib0665","first-page":"265","article-title":"Challenges to chimeric antigen receptor (CAR)-T cell therapy for cancer","volume":"18","author":"Magee","year":"2014","journal-title":"Discov. Med."},{"key":"10.1016\/j.imlet.2017.01.010_bib0670","doi-asserted-by":"crossref","first-page":"4099","DOI":"10.1182\/blood-2010-04-281931","article-title":"Eradication of B-lineage cells and regression of lymphoma in a patient treated with autologous T cells genetically engineered to recognize CD19","volume":"116","author":"Kochenderfer","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.imlet.2017.01.010_bib0675","doi-asserted-by":"crossref","first-page":"95ra73","DOI":"10.1126\/scitranslmed.3002842","article-title":"T cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced leukemia","volume":"3","author":"Kalos","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.imlet.2017.01.010_bib0680","doi-asserted-by":"crossref","first-page":"224ra225","DOI":"10.1126\/scitranslmed.3008226","article-title":"Efficacy and toxicity management of 19\u201328z CAR T cell therapy in B cell acute lymphoblastic leukemia","volume":"6","author":"Davila","year":"2014","journal-title":"Sci. Transl. Med."}],"container-title":["Immunology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016524781630236X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016524781630236X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T00:20:08Z","timestamp":1692663608000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016524781630236X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":136,"alternative-id":["S016524781630236X"],"URL":"https:\/\/doi.org\/10.1016\/j.imlet.2017.01.010","relation":{},"ISSN":["0165-2478"],"issn-type":[{"value":"0165-2478","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CD19, from bench to bedside","name":"articletitle","label":"Article Title"},{"value":"Immunology Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imlet.2017.01.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 European Federation of Immunological Societies. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}